Komova Olga, Krasavin Eugene, Nasonova Elena, Mel'nikova Larisa, Shmakova Nina, Cunha Micaela, Testa Etienne, Beuve Michaël
a Laboratory of Radiation Biology, Department of Radiation Cytology, Joint Institute for Nuclear Research (JINR) , Dubna , Russia.
b Department of Radiation Sciences , Université de Lyon , Lyon , France.
Int J Radiat Biol. 2018 Jan;94(1):54-61. doi: 10.1080/09553002.2018.1399226. Epub 2017 Nov 20.
Our study aimed at evaluating: 1) whether well-established variability in radioadaptive response (AR) in various donor blood lymphocytes might be attributed to inter-individual differences in radiosensitivity to different low dose levels; 2) whether AR is reproducibly present over time in the lymphocytes of AR-positive individuals. Experimental procedure: Whole blood samples of three donors were exposed to low doses (2-30 cGy) of γ-radiation alone (G phase) or followed by a 1 Gy challenge dose (late S/early G phase), and chromosome aberration were scored to assess the dose-response relationship and adaptive response, correspondingly. Three experiments were performed on blood samples of the same donors at six month intervals.
Significant differences in dose response relationship for blood lymphocytes were found among individuals. In most cases, the donors exhibited initial low-dose hypersensitivity (HRS) followed by an increase in radioresistance (IRR). AR could be successfully induced by some particular priming doses in the lymphocytes of each donor; however, the doses resulting in a protective response were quite different for all three donors. These protective doses could equally belong to either HRS or IRR region on the individual dose-response curves. In most cases, no clear AR outcome dependence on the priming dose was found at all. Moreover, pre-exposure to the same low dose could result in opposite effects in the lymphocytes of the same donor in different experiments.
AR variability in human lymphocytes is not attributed to variation in radiosensitivity among individuals and is more drastic than was believed. It seems doubtful that AR is a universal phenomenon which has a consistent impact on the effects of radiation exposure on humans.
我们的研究旨在评估:1)不同供体血液淋巴细胞中已确立的辐射适应性反应(AR)变异性是否可归因于对不同低剂量水平放射敏感性的个体差异;2)AR在AR阳性个体的淋巴细胞中是否随时间可重复出现。实验步骤:采集三名供体的全血样本,单独暴露于低剂量(2 - 30 cGy)的γ射线(G期)或随后给予1 Gy的激发剂量(S期末/ G期早期),并对染色体畸变进行评分,以相应评估剂量反应关系和适应性反应。对同一供体的血液样本每隔六个月进行三次实验。
个体之间血液淋巴细胞的剂量反应关系存在显著差异。在大多数情况下,供体表现出初始低剂量超敏感性(HRS),随后放射抗性增加(IRR)。每个供体的淋巴细胞可通过某些特定的预照射剂量成功诱导出AR;然而,对所有三名供体而言,产生保护反应的剂量差异很大。这些保护剂量在个体剂量反应曲线上既可以属于HRS区域,也可以属于IRR区域。在大多数情况下,根本未发现AR结果对预照射剂量有明确依赖性。此外,在不同实验中,对同一供体的淋巴细胞预先暴露于相同低剂量可能会产生相反的效果。
人类淋巴细胞中的AR变异性并非归因于个体间放射敏感性的差异,且比人们认为的更为显著。AR是否是一种对辐射暴露对人类的影响具有一致作用的普遍现象,这一点似乎值得怀疑。